FindTrial
Sign In

Recovery characteristics of Ropivacaine 0.75 percentage in patients undergoing endovenous laser ablation surgery for varicose veins under spinal anaesthesia within the age group of 20-80 years

Recovery characteristics of Intrathecal Hyperbaric Ropivacaine 0.75 percentage in patients undergoing endovenous laser ablation surgery for varicose veins within the age group of 20-80 years- An observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090062
Enrollment
64
Registered
2025-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I83- Varicose veins of lower extremities

Interventions

Intervention1: Nil: Nil

Sponsors

Institutional Fluid Research grant of Christian Medical College, Vellore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients giving consent between the age group of 20-80 years, who are undergoing endovenous laser ablation surgery for varicose veins.

Exclusion criteria

Exclusion criteria: PREGNANT WOMAN LUMBAR SPINE DISEASE PAST HISTORY OF LUMBAR SPINE SURGERIES

Design outcomes

Primary

MeasureTime frame
TO OBSERVE THE MOTOR RECOVERY PERIOD OF 0.75 PERCENT HYPERBARIC INTRATHECAL ROPIVACAINETimepoint: LESS THAN 4 HOURS- IN POST ANAESTHESIA CARE UNIT—

Secondary

MeasureTime frame
HIGHEST SENSORY LEVEL ACHIEVED WITH INTRATHECAL 0.75 PERCENT HYPERBARIC ROPIVACAINETimepoint: 30 MINUTES;TIME TAKEN TO ATTAIN T12 SENSORY LEVEL- READINESS FOR SURGERYTimepoint: 30 MINUTES;ADVERSE OUTCOMES- BRADYCARDIA, HYPOTENSION, NAUSEA, VOMITING, RESPIRATORY DEPRESSIONTimepoint: 3 HOURS;TIME TAKEN FOR DISCHARGE- MODIFIED ALDRETTE SCORETimepoint: 4 HOURS;POST OPERATIVE ANALGESIA REQUIREMENT IN PACUTimepoint: 4 HOURS—

Countries

India

Contacts

Public ContactChitra S

CHRISTIAN MEDICAL COLLEGE

chitraanaes73@gmail.com9965565990

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026